Literature DB >> 12016142

Effects of resistant starch and nonstarch polysaccharides on colonic luminal environment and genotoxin-induced apoptosis in the rat.

R K Le Leu1, Y Hu, G P Young.   

Abstract

Fermentation of polysaccharides in the colon seems likely to regulate tumorigenesis but the mechanisms are unclear. A possible mechanism may be through facilitation of the acute apoptotic response to genotoxin-induced DNA damage. This study evaluated the effects of selected dietary polysaccharides, resistant starch (supplied as Hi-maize) and nonstarch polysaccharides (supplied as wheat bran and cellulose) on certain biological events relevant to protection against colon cancer (fecal bulk, pH, butyrate and apoptosis). Male Sprague-Dawley rats were fed the different experimental diets for a period of 4 weeks, after which a single azoxymethane injection was given to induce DNA damage; 6 h later the acute apoptotic response was measured. Other measures included short chain fatty acid (SCFA) levels, fecal bulk and pH. All wheat bran treatments significantly (P < 0.05) enhanced carcinogen-induced apoptosis in the distal colon, increased fecal bulk and butyrate levels and reduced fecal pH, when compared with rats fed NF or Cellulose diets. Total SCFA (P < 0.001, r = 0.496) and butyrate levels (P < 0.001, r = 0.353) in the feces correlated positively with the acute apoptotic response in distal colonic crypts. Resistant starch supplementation by this modest amount did not enhance carcinogen-induced apoptosis. While it did significantly increase bulk, SCFA and butyrate levels and lower pH, the magnitude of these effects was not as great as with wheat bran. These findings indicate that wheat bran is the most effective regulator of these biological events of relevance to protection against colon cancer. Assuming that the acute apoptotic response to genotoxic carcinogens acts to remove genetically damaged cells that might otherwise form mutated clones that progress to malignancy, we have identified an additional biological mechanism by which dietary polysaccharides provide protection.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12016142     DOI: 10.1093/carcin/23.5.713

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  13 in total

1.  Fasting and engineered diets as powerful tool in the medical practice: an old approach in the new era.

Authors:  Concetta Panebianco; Adele Potenza; Valerio Pazienza
Journal:  Ann Transl Med       Date:  2017-11

2.  Screening of stimulatory effects of dietary risk factors on mouse intestinal cell kinetics.

Authors:  Pooja Shivshankar; Shyamala-C-S Devi
Journal:  World J Gastroenterol       Date:  2005-01-14       Impact factor: 5.742

3.  Site specific delivery of microencapsulated fish oil to the gastrointestinal tract of the rat.

Authors:  Glen S Patten; Mary Ann Augustin; Luz Sanguansri; Richard J Head; Mahinda Y Abeywardena
Journal:  Dig Dis Sci       Date:  2008-07-10       Impact factor: 3.199

Review 4.  Resistant starch: promise for improving human health.

Authors:  Diane F Birt; Terri Boylston; Suzanne Hendrich; Jay-Lin Jane; James Hollis; Li Li; John McClelland; Samuel Moore; Gregory J Phillips; Matthew Rowling; Kevin Schalinske; M Paul Scott; Elizabeth M Whitley
Journal:  Adv Nutr       Date:  2013-11-06       Impact factor: 8.701

5.  Butyrate delivered by butyrylated starch increases distal colonic epithelial apoptosis in carcinogen-treated rats.

Authors:  Julie M Clarke; Graeme P Young; David L Topping; Anthony R Bird; Lynne Cobiac; Benjamin L Scherer; Jessica G Winkler; Trevor J Lockett
Journal:  Carcinogenesis       Date:  2011-11-10       Impact factor: 4.944

6.  Effect of high amylose maize starches on colonic fermentation and apoptotic response to DNA-damage in the colon of rats.

Authors:  Richard K Le Leu; Ying Hu; Ian L Brown; Graeme P Young
Journal:  Nutr Metab (Lond)       Date:  2009-03-07       Impact factor: 4.169

7.  Butyrylated starch intake can prevent red meat-induced O6-methyl-2-deoxyguanosine adducts in human rectal tissue: a randomised clinical trial.

Authors:  Richard K Le Leu; Jean M Winter; Claus T Christophersen; Graeme P Young; Karen J Humphreys; Ying Hu; Silvia W Gratz; Rosalind B Miller; David L Topping; Anthony R Bird; Michael A Conlon
Journal:  Br J Nutr       Date:  2015-06-17       Impact factor: 3.718

8.  A study protocol to investigate the relationship between dietary fibre intake and fermentation, colon cell turnover, global protein acetylation and early carcinogenesis: the FACT study.

Authors:  Bernard M Corfe; Elizabeth A Williams; Jonathan P Bury; Stuart A Riley; Lisa J Croucher; Daphne Y L Lai; Caroline A Evans
Journal:  BMC Cancer       Date:  2009-09-18       Impact factor: 4.430

9.  Gastrointestinal and hepatotoxicity assessment of an anticancer extract from muricid molluscs.

Authors:  Chantel B Westley; Kirsten Benkendorff; Cassandra M McIver; Richard K Le Leu; Catherine A Abbott
Journal:  Evid Based Complement Alternat Med       Date:  2013-04-17       Impact factor: 2.629

10.  6-bromoisatin found in muricid mollusc extracts inhibits colon cancer cell proliferation and induces apoptosis, preventing early stage tumor formation in a colorectal cancer rodent model.

Authors:  Babak Esmaeelian; Catherine A Abbott; Richard K Le Leu; Kirsten Benkendorff
Journal:  Mar Drugs       Date:  2013-12-24       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.